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Abstract
Background: Mycoplasma pneumoniae infection is usually self-limited, but some fulminant cases are fatal, even
when occurring in previously healthy individuals. It can also be the cause of overwhelming postsplenectomy
infection (OPSI).
Case presentation: We report a case of OPSI in a 41-year-old woman with hypersplenism associated with hepatitis
B cirrhosis. We detected a significant Mycoplasma pneumoniae agglutination titer, but no evidence of infection with
Chlamydia pneumoniae, Legionnella spp., or any other bacterial or fungal pathogens. She eventually died despite
aggressive therapy.
Conclusions: M. pneumoniae could be an underestimated cause of OPSI, and should be suspected in fulminant
infectious cases in asplenic patients.
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Background
Overwhelming postsplenectomy infection (OPSI) is a rare
condition and extremely dangerous in asplenic indivi-
duals. The most common pathogen associated with OPSI
is Streptococcus pneumoniae [1]. There have not been
any published case reports on OPSI, in which Myco-
plasma pneumoniae was implicated. We report here on
an adult patient who had undergone splenectomy for
hypersplenism associated with hepatitis B cirrhosis
and eventually developed OPSI possibly caused by
M. pneumoniae.
Case presentation
On November 14, 2010, a 41-year-old woman was
admitted to our hospital with complaints of high fever
and chills of 10-hour duration. Three weeks prior she
had undergone a splenectomy for pancytopenia asso-
ciated with splenomegaly caused by hepatitis B cirrhosis-
related portal hypertension without esophageal varices
(Figure 1). Her postoperative course was uneventful, and
she was discharged 14 days after her operation. Due to
her non-compliance, she was not administered the
immunoprophylaxis vaccination. Immediately before her
onset of fever, she had taken a sponge bath. Acetamino-
phen did not relieve the fever, and she was admitted to
the local hospital 3 hours later when her temperature
was 40.5°C. Her physicians only treated the fever and did
not administer antibiotics. Three hours later she became
disoriented, astatic, and incontinent of urine. At this time
she was admitted to our hospital. On initial physical
examination, her temperature was 38.2°C; blood pressure,
52/26 mm Hg; pulse rate, 130 beats/min; and respiratory
rate, 24 breaths/min. She was conscious. Lip cyanosis,
skin petechiae, and ecchymoses were not noted. Her pul-
monary examination was unremarkable, and her abdo-
men had no tenderness or rebound tenderness. Her
extremities were cold and no edema was present. Abnor-
mal laboratory findings included the following: white
blood cell count (WBC), 11,800/mm3; percent neutro-
phils, 97.6%; lymphocyte count, 200/mm3; hemoglobin,
83 g/L; platelet count, 217 × 103/mm3; albumin, 22.6 g/L;
prothrombin time (PT), 18.9 sec; fibrinogen, 0.9 g/L;
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D-dimers, 2098 μg/L; pH, 7.091; ABE, -20.9 mmol/L;
HCO3
-, 7.2 mmol/L; and pCO2, 24.8 mm Hg. Her bed-
side abdominal ultrasound was unremarkable.
During her admission evaluation, she received intrave-
nous normal saline, plasma, and dopamine (14 μg/kg/
min). Her blood pressure increased to 90/62 mm Hg.
After she was diagnosed with OPSI and septic shock
syndrome, she received intravenous imipenem plus
cilastatin 1 g, ulinastatin 100,000 U, and hydrocortisone
100 mg. Sodium bicarbonate was given to alleviate
metabolic acidosis. She developed hemodynamic
instability 4 hours later, and her blood pressure
decreased to 72/31 mm Hg. She was then transferred to
intensive care unit, where central venous catheters were
introduced for fluid resuscitation, and norepinephrine
and dopamine were administered to maintain blood
pressure. She received oxygen and was given intravenous
vancomycin, linezolid and ornidazole. At first her condi-
tion improved, only slightly, but twenty hours after
admission, the patient became dyspneic and received
noninvasive mechanical ventilation.
Results of additional laboratory tests were as follows:
WBC, 26,800/mm3; PT, 21.7 sec; D-dimers, 3767 μg/L;
fibrinogen degradation products (FDP), 181.4 mg/L; tro-
ponin I, 18.84 ng/mL; and lactic acid, 11.7 mmol/L.
Agglutinating antibodies to Chlamydia pneumoniae and
Legionnella spp. were negative, but significant agglutina-
tion titers of 1:640 were seen for M. pneumoniae. Bed-
side chest radiography revealed diffuse bilateral
infiltrates, and the bedside ultrasound revealed hydro-
thorax and ascites (Figure 2). After infection with myco-
plasma was established, azithromycin was administered
intravenously. Nine hours later, her arterial oxygen
saturation decreased to 71%, and an endotracheal tube
was inserted to support respiration. Hemodialysis was
performed to correct lactic acidosis. Fifty-four hours
after admission, despite intensive treatment, she devel-
oped progressive hemodynamic deterioration and disse-
minated intravascular coagulation (DIC). Due to
financial concerns, she was discharged without further
treatment. She died immediately after returning to her
home. An autopsy wasn’t preformed due to the hus-
band’s request. Cultures of blood, sputum, and drainage
fluid were all negative for bacteria and fungi.
Conclusions
The spleen is the largest organ of the lymphatic system,
and is crucial for host response to infection because of
its function in removing microorganisms and their pro-
ducts from the circulation. It is also the site of antibody
production. So asplenic patients are immunocompro-
mised, with a high rate of morbidity and mortality from
fulminant sepsis. 4.4% of children under 16 years of age
who receive a splenectomy will develop OPSI, as com-
pared to only 0.9% of adults who have the same proce-
dure [2]. The mortality rate is still 50% to 70% despite
improvements in antibiotic therapy and intensive care
[1]. In asplenic patients, the increased risk of OPSI is
lifelong ordeal. During the first 4 years after splenect-
omy, 50% to 70% of patients with OPSI were hospita-
lized [3]. OPSI has a remarkably broad occurrence
timetable. It has been reported to occur from 24 days to
long as 65 years after a splenectomy [3]. Our patient
developed OPSI only 21 days after her splenectomy pro-
cedure. In her case, the development of OPSI may have
Figure 1 Contrast computed tomography revealing splenomegaly
and varicose veins (triangles).
Figure 2 Chest x-ray showing diffuse infiltrates.
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also been associated with hepatitis B cirrhosis, which is
manifested by protein and energy malnutrition and
reduced host immune response [4,5]. Resecting the
spleen caused her immune system to be even more vul-
nerable to attack, thereby increasing her susceptibility to
OPSI.
Sepsis in splenectomized patients can develop after
infection with any organism, including bacteria, viruses,
fungi, and protozoa; however, encapsulated organisms
are most frequently associated with sepsis in asplenic
patients. Streptococcus pneumoniae, responsible for 50%
to 90% of cases, is the most dangerous pathogen. Hae-
mophilus influenzae type B, Neisseria meningitidis, and
group A Streptococcus have accounted for additional
infections [6]. In our patient, cultures of blood, sputum,
and drainage fluid, all collected before antibiotic admin-
istration, were negative for bacteria and fungi. Serologi-
cal testing was strongly positive for agglutinating
antibodies to M. pneumoniae (1:640), and bedside chest
radiography revealed diffuse bilateral infiltrates. Con-
firmed diagnosis of M. pneumoniae is often difficult and
is mostly based on serological methods, which require
highly acute antibody titers or paired serum samples for
definitive diagnosis, since direct detection or culture is
time consuming and not readily available [7]. Given this
information, while we are unable to obtain definitive
evidence of a link, it is our opinion that an acute M.
pneumoniae infection was a primary factor in the
patient’s development of OPSI.
Mycoplasma species infection is highly prevalent in
the general population, and is usually self-limited. The
occurrence of fulminant cases is very rare, primarily
occurring in patients with sickle cell trait and related
hemoglobinopathies or hypogammaglobulinemia, but it
also occurs in previously healthy individuals [8]. An
English-language MEDLINE database search on fatal M.
pneumoniae infections revealed that death was usually
due to acute disseminated encephalomyelitis, adult
respiratory distress syndrome (ARDS), or vascular
thrombosis and DIC, and did not bear any mention of a
patient dying from OPSI [7,9,10]. The pathogenic
mechanisms involved in these fatal conditions are so far
unknown, and most probably involve immune cell-
mediated tissue damage. Narita suggested that extra pul-
monary manifestations of M. pneumoniae infection
could be classified into 3 categories. One mechanism
involves inflammatory cytokines locally induced by lipo-
proteins contained in the bacterial cell membrane, while
a second involves a form of immune modulation such
as autoimmunity resulting from cross-reactivity between
bacterial cell components and human cells. Still a third
involves vascular occlusion caused by vasculitis and/or
thrombosis with or without systemic hypercoagulability,
induced by the bacterium [11].
It is well known that treatment of M. pneumoniae is
effective only when macrolides are administered early in
the course of infection. We did not diagnose Myco-
plasma infection in the patient until one day after she
had been admitted to the hospital. It seems that this
delay in starting treatment was the primary factor in
poor response to high doses of azithromycin. Our
patient developed progressive respiratory failure and
DIC and eventually died, despite receiving aggressive
therapy that included intravenous fluids, antibiotics,
vasopressors, steroids, heparin, packed red blood cells,
fresh frozen plasma, and continuous hemodiafiltration
and plasma exchange.
Prevention of OPSI is paramount in immunocompro-
mised asplenic patients because of its high mortality
rate. Recommended preventive strategies include educa-
tion of patients and relatives, which include, but are not
limited to the vaccine immunoprophylaxis against pneu-
monia, influenza, and meningitis as well as lifelong che-
moprophylaxis [12-14]. Asplenic patients should avoid
animal and tick bites, and malaria in endemic malaria
regions, and should be treated immediately in such set-
tings [12].
Patient education on the potential risks of infection
must be reinforced throughout the asplenic patient’s life.
A previous study has shown that 55.2% of asplenic
patients had poor awareness of the risks of splenectomy,
and only 1.4% of aware patients developed OPSI com-
pared to 16.5% of patients with poor knowledge of OPSI
risks [15]. Therefore, some form of medical alert, such
as a bracelet or a card, should be carried by asplenic
individuals for constant reminder of their condition and
for medical attendants in the event of a medical emer-
gency [13,16]. A spleen registry should also be estab-
lished to ensure that asplenic patients, family members,
and caregivers have easy access to the most current
recommendations for the prevention of OPSI [12].
A polysaccharide-based pneumococcal vaccine is
recommended for all asplenic individuals, however the
timing of vaccination is very important. The optimal
time is at least 2 weeks before elective splenectomy
about 2 weeks postoperatively for emergency patients,
and revaccination every 5-10 years is recommended
[12,16]. Studies reveal that no OPSI has been seen in
patients vaccinated before splenectomy; however, 5% of
patients receiving vaccination after surgery developed
OPSI, and 10.4% of patients who were not vaccinated
developed OPSI [14,17]. Influenza immunization, in a
manner, is more important than pneumococcal immuni-
zation [14].
The use of antibiotic prophylaxis remains controver-
sial with some because there currently is no clear clini-
cal data demonstrating its efficacy in asplenic patients,
and commonly used antibiotics may result in increased
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resistance to antimicrobials. However, the Australian
Therapeutic Guidelines recommend daily amoxicillin
and/or a macrolide for at least 2 years postoperatively
[12].
In conclusion, M. pneumoniae may be a pathogen
involved in OPSI, which is a rapidly progressive condi-
tion with a high mortality rate and should be treated
aggressively. Extremely important prevention strategies
include education, vaccination, and chemoprophylaxis.
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